Taken together, our results provide evidence that celastrol exerts anti-arthritic effects by inhibiting LPS-induced RA-FLS migration and invasion, and the mechanisms may involve the suppression of TLR4/NF-κB-mediated MMP-9 expression. The gene discussed is NFKB1; the disease is rheumatoid arthritis.